Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer.
Biomol Ther (Seoul)
; 30(3): 274-283, 2022 May 01.
Article
in En
| MEDLINE
| ID: mdl-34663758
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Biomol Ther (Seoul)
Year:
2022
Type:
Article